Medical tech firm Nuwellis Q3 revenue down 6% yr/yr
I'm PortAI, I can summarize articles.
Nuwellis reported a 6% year-over-year decline in Q3 revenue, totaling $2.22 million, but saw a 29% increase sequentially. The company achieved a net income of $468,000, with earnings per share of $0.56. Nuwellis is transitioning its manufacturing to focus on U.S. market growth and is exiting international operations. The firm is enhancing its product offerings and advancing pediatric product development through a collaboration funded by the NIH.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments